Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

{
  "signal_id": "09bf3107-0060-dff1-220b-b00c1ba40075",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-08-12T10:30:00+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/bio-techne-releases-fourth-quarter-fiscal-2026-results-302849060.html",
    "title": "Bio-Techne Releases Fourth Quarter Fiscal 2026 Results",
    "excerpt": "MINNEAPOLIS , Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today reported its financial results for the fourth quarter ending June 30, 2026. Fourth Quarter FY2026 Highlights \"Bio-Techne ended fiscal 2026 with improved performance and solid execution across the business, reflecting the value our differentiated solutions bring across biopharma, research and diagnostic workflows,\" said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. \"We continue to make progress toward completing Bio-Techne's acquisition by Merck KGaA, Darmstadt, Germany, and look forward to the opportunities this transaction is expected to create for our customers and employees.\" Conference Call In light of the announced transaction with Merck KGaA, Darmstadt, Germany, Bio-Techne is no longer holding investor conference calls for quarterly results. Fourth Quarter Fiscal 2026 Revenue Net sales for the fourth quarter increased 1% to $321.2 million. Organic growth increased 3% compared to the prior year. Non-recurring prior year revenue from a business held-for-sale had an unfavorable impact of 2% and foreign currency exchange did not have a material impact. GAAP Earnings Results GAAP EPS was $0.35 per diluted share versus $(0.11) in the same quarter last year. GAAP operating income for the fourth quarter of fiscal 2026 was $74.3 million compared to an operating loss of...",
    "summary": "Bio-Techne Corporation reported GAAP EPS of $1.16 per diluted share for the full fiscal year 2026.",
    "location": "Minneapolis, Minnesota, USA",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS402613/Bio-Techne-Logo.jpg?id=OA2862148&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-08-12T10:30:00Z",
    "location_data": [
      {
        "city": "Minneapolis",
        "state": "Minnesota",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-30",
    "article_sentence": "GAAP EPS was $1.16 per diluted share, compared to $0.46 last fiscal year.",
    "amount_normalized": 1
  }
}

curl https://signals.autobound.ai/v1/signals/09bf3107-0060-dff1-220b-b00c1ba40075 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bio-techne.com","limit":20}'